Loading…
Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity
Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were...
Saved in:
Published in: | International journal of cancer 1999-07, Vol.82 (2), p.293-297 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13 |
container_end_page | 297 |
container_issue | 2 |
container_start_page | 293 |
container_title | International journal of cancer |
container_volume | 82 |
creator | Blackburn, Robert V. Galoforo, Sandra S. Corry, Peter M. Lee, Yong J. |
description | Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1097-0215(19990719)82:2<293::AID-IJC22>3.0.CO;2-H |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17307576</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17307576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEotPCKyAvEGoXmV7bSZxMEWgUfiao0iwAwc7y2E5rSJwSO63yILwvzmT4kUBCXlg6-nx87j1R9BLDEgOQ89P3VVmdYShYDASnp7goCmC4OMvJijwnBV2t1tWruHpXEvKCLmFZbi9IvLkXLX69uR8tghPEDNPsKDp27gsAxikkD6MjDDQvWJYtou9rpW13a3rRIN8L69Qgveks6mokkBx954zVSGnRGiucPvfXY2vUpH3dC6ge3MRf6SAZ6zt003fOC6-RFL00tmuDj24ah7S9FlZqNxGqH66QsAr1Qhmx_9Fp64w3t8aPj6IHtWicfny4T6KPb15_KDfx5fZtVa4vY0kTSuIEq1TuBMtVuks1hSyDtFaEKZ0XNcFslzCscAIJqB3GMgeZAFYFTVNgJKsxPYmezb4h0bdBO89b46awwupucBwzCixlWQA_zaAMw7le1_ymN63oR46BT41xPjXGp-3zafv8Z2M8JzycgnIeGuP7xjjlwMtt0DfB-ckhwrBrtfrDd64oAE8PgHBSNHUoSRr3m8tZkpIkYJ9n7M40evwr3n_T_SvcLNAfIRDBUA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17307576</pqid></control><display><type>article</type><title>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</title><source>Wiley</source><creator>Blackburn, Robert V. ; Galoforo, Sandra S. ; Corry, Peter M. ; Lee, Yong J.</creator><creatorcontrib>Blackburn, Robert V. ; Galoforo, Sandra S. ; Corry, Peter M. ; Lee, Yong J.</creatorcontrib><description>Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/(SICI)1097-0215(19990719)82:2<293::AID-IJC22>3.0.CO;2-H</identifier><identifier>PMID: 10389766</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Adenoviridae - genetics ; Animals ; Antimetabolites - pharmacology ; Antimetabolites, Antineoplastic - pharmacology ; Antiviral Agents - pharmacology ; Biological and medical sciences ; Biotechnology ; Carcinoma - pathology ; Carcinoma - radiotherapy ; Carcinoma - therapy ; Cytomegalovirus - genetics ; Cytosine Deaminase ; Flucytosine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Ganciclovir - pharmacology ; Gene Expression Regulation, Neoplastic ; Gene Expression Regulation, Viral ; Gene therapy ; Genetic Therapy ; Genetic Vectors - genetics ; Health. Pharmaceutical industry ; Humans ; Industrial applications and implications. Economical aspects ; Male ; Nucleoside Deaminases - genetics ; Prodrugs - pharmacology ; Promoter Regions, Genetic ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - radiotherapy ; Prostatic Neoplasms - therapy ; Radiation Tolerance - drug effects ; Radiation Tolerance - genetics ; Rats ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - metabolism ; Thymidine Kinase - genetics ; Tumor Cells, Cultured - drug effects ; Tumor Cells, Cultured - radiation effects</subject><ispartof>International journal of cancer, 1999-07, Vol.82 (2), p.293-297</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1874524$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10389766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Blackburn, Robert V.</creatorcontrib><creatorcontrib>Galoforo, Sandra S.</creatorcontrib><creatorcontrib>Corry, Peter M.</creatorcontrib><creatorcontrib>Lee, Yong J.</creatorcontrib><title>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>Adenoviridae - genetics</subject><subject>Animals</subject><subject>Antimetabolites - pharmacology</subject><subject>Antimetabolites, Antineoplastic - pharmacology</subject><subject>Antiviral Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - radiotherapy</subject><subject>Carcinoma - therapy</subject><subject>Cytomegalovirus - genetics</subject><subject>Cytosine Deaminase</subject><subject>Flucytosine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Ganciclovir - pharmacology</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene Expression Regulation, Viral</subject><subject>Gene therapy</subject><subject>Genetic Therapy</subject><subject>Genetic Vectors - genetics</subject><subject>Health. Pharmaceutical industry</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Male</subject><subject>Nucleoside Deaminases - genetics</subject><subject>Prodrugs - pharmacology</subject><subject>Promoter Regions, Genetic</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Radiation Tolerance - drug effects</subject><subject>Radiation Tolerance - genetics</subject><subject>Rats</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Thymidine Kinase - genetics</subject><subject>Tumor Cells, Cultured - drug effects</subject><subject>Tumor Cells, Cultured - radiation effects</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAUhSMEotPCKyAvEGoXmV7bSZxMEWgUfiao0iwAwc7y2E5rSJwSO63yILwvzmT4kUBCXlg6-nx87j1R9BLDEgOQ89P3VVmdYShYDASnp7goCmC4OMvJijwnBV2t1tWruHpXEvKCLmFZbi9IvLkXLX69uR8tghPEDNPsKDp27gsAxikkD6MjDDQvWJYtou9rpW13a3rRIN8L69Qgveks6mokkBx954zVSGnRGiucPvfXY2vUpH3dC6ge3MRf6SAZ6zt003fOC6-RFL00tmuDj24ah7S9FlZqNxGqH66QsAr1Qhmx_9Fp64w3t8aPj6IHtWicfny4T6KPb15_KDfx5fZtVa4vY0kTSuIEq1TuBMtVuks1hSyDtFaEKZ0XNcFslzCscAIJqB3GMgeZAFYFTVNgJKsxPYmezb4h0bdBO89b46awwupucBwzCixlWQA_zaAMw7le1_ymN63oR46BT41xPjXGp-3zafv8Z2M8JzycgnIeGuP7xjjlwMtt0DfB-ckhwrBrtfrDd64oAE8PgHBSNHUoSRr3m8tZkpIkYJ9n7M40evwr3n_T_SvcLNAfIRDBUA</recordid><startdate>19990719</startdate><enddate>19990719</enddate><creator>Blackburn, Robert V.</creator><creator>Galoforo, Sandra S.</creator><creator>Corry, Peter M.</creator><creator>Lee, Yong J.</creator><general>John Wiley & Sons, Inc</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>19990719</creationdate><title>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</title><author>Blackburn, Robert V. ; Galoforo, Sandra S. ; Corry, Peter M. ; Lee, Yong J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adenoviridae - genetics</topic><topic>Animals</topic><topic>Antimetabolites - pharmacology</topic><topic>Antimetabolites, Antineoplastic - pharmacology</topic><topic>Antiviral Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - radiotherapy</topic><topic>Carcinoma - therapy</topic><topic>Cytomegalovirus - genetics</topic><topic>Cytosine Deaminase</topic><topic>Flucytosine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Ganciclovir - pharmacology</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene Expression Regulation, Viral</topic><topic>Gene therapy</topic><topic>Genetic Therapy</topic><topic>Genetic Vectors - genetics</topic><topic>Health. Pharmaceutical industry</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Male</topic><topic>Nucleoside Deaminases - genetics</topic><topic>Prodrugs - pharmacology</topic><topic>Promoter Regions, Genetic</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Radiation Tolerance - drug effects</topic><topic>Radiation Tolerance - genetics</topic><topic>Rats</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Thymidine Kinase - genetics</topic><topic>Tumor Cells, Cultured - drug effects</topic><topic>Tumor Cells, Cultured - radiation effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Blackburn, Robert V.</creatorcontrib><creatorcontrib>Galoforo, Sandra S.</creatorcontrib><creatorcontrib>Corry, Peter M.</creatorcontrib><creatorcontrib>Lee, Yong J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Blackburn, Robert V.</au><au>Galoforo, Sandra S.</au><au>Corry, Peter M.</au><au>Lee, Yong J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1999-07-19</date><risdate>1999</risdate><volume>82</volume><issue>2</issue><spage>293</spage><epage>297</epage><pages>293-297</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Prostate tumor cells (PC‐3) were transduced with defective, recombinant adenovirus containing a fusion gene encoding the Escherichia coli cytosine deaminase and herpes simplex virus type‐1 thymidine kinase under the control of a cytomegalovirus promoter. Expression levels of the fusion protein were dependent on the multiplicity of infection used and incubation time following infection. PC‐3 cells expressing this protein were sensitized to killing by the normally innocuous prodrugs 5‐fluorocytosine and ganciclovir. In addition, radiation‐induced killing was enhanced in virally infected cells in the presence of the prodrugs. Int. J. Cancer 82:293–297, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>10389766</pmid><doi>10.1002/(SICI)1097-0215(19990719)82:2<293::AID-IJC22>3.0.CO;2-H</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7136 |
ispartof | International journal of cancer, 1999-07, Vol.82 (2), p.293-297 |
issn | 0020-7136 1097-0215 |
language | eng |
recordid | cdi_proquest_miscellaneous_17307576 |
source | Wiley |
subjects | Adenoviridae - genetics Animals Antimetabolites - pharmacology Antimetabolites, Antineoplastic - pharmacology Antiviral Agents - pharmacology Biological and medical sciences Biotechnology Carcinoma - pathology Carcinoma - radiotherapy Carcinoma - therapy Cytomegalovirus - genetics Cytosine Deaminase Flucytosine - pharmacology Fundamental and applied biological sciences. Psychology Ganciclovir - pharmacology Gene Expression Regulation, Neoplastic Gene Expression Regulation, Viral Gene therapy Genetic Therapy Genetic Vectors - genetics Health. Pharmaceutical industry Humans Industrial applications and implications. Economical aspects Male Nucleoside Deaminases - genetics Prodrugs - pharmacology Promoter Regions, Genetic Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - therapy Radiation Tolerance - drug effects Radiation Tolerance - genetics Rats Recombinant Fusion Proteins - genetics Recombinant Fusion Proteins - metabolism Thymidine Kinase - genetics Tumor Cells, Cultured - drug effects Tumor Cells, Cultured - radiation effects |
title | Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A13%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adenoviral%20transduction%20of%20a%20cytosine%20deaminase/thymidine%20kinase%20fusion%20gene%20into%20prostate%20carcinoma%20cells%20enhances%20prodrug%20and%20radiation%20sensitivity&rft.jtitle=International%20journal%20of%20cancer&rft.au=Blackburn,%20Robert%20V.&rft.date=1999-07-19&rft.volume=82&rft.issue=2&rft.spage=293&rft.epage=297&rft.pages=293-297&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/(SICI)1097-0215(19990719)82:2%3C293::AID-IJC22%3E3.0.CO;2-H&rft_dat=%3Cproquest_cross%3E17307576%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3432-41d5cba78d5b5e306605fd27de89f217b471d14040db11c80c401d93550726f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17307576&rft_id=info:pmid/10389766&rfr_iscdi=true |